RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 2002; 87(05): 777-778
DOI: 10.1055/s-0037-1613082
DOI: 10.1055/s-0037-1613082
Commentary
Prothrombotic Genotypes and Pre-eclampsia
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
11. Dezember 2017 (online)
-
References
- 1 Meekins JW, Pijnenborg R, Hanssens M, Mc Fadyen IR, van Aashe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Brit J Obstet Gynaecol 1994; 101: 669-74.
- 2
Redman CW,
Sargent IL.
Placental debris, oxidative stress and pre-eclampsia. Placenta 2000; 21: 597-602.
MissingFormLabel
- 3 Knight M, Redman CW, Linton EA, Sargent IL. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Brit J Obstet Gynaecol 1998; 105: 632-40.
- 4 Salafia CM, Pezzullo JC, Lopez-Zeno JA, Simmens S, Minior VK, Vintzileos AM. Placental pathologic features of preterm pre-eclampsia. Am J Obstet Gynecol 1995; 173: 1097-105.
- 5 Campbell DM, Mac Gillivray I, Carr-Hill R. Pre-eclampsia in second pregnancy. Brit J Obstet Gynaecol 1985; 92: 131-40.
- 6 Mogren I, Hogberg U, Winkvist A, Stenlund H. Familial occurrence of preeclampsia. Epidemiology 1999; 10: 518-22.
- 7 Dekker GA, Sibai BM. Etiology and pathogenesis of pre-eclampsia: current concepts. Am J Obstet Gynecol 1998; 179: 1359-75.
- 8 Chesley LC, Cooper DW. Genetics of hypertension in pregnancy: possible single gene control of pre-eclampsia and eclampsia in descendants of eclamptic women. Brit J Obstet Gynaecol 1986; 93: 898-908.
- 9 Mousa HA, Alfirevic IZ. Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?. Hum Reprod 2000; 16: 1830-3.
- 10 Dekker GA, de Vries JI, Doelitzsch PM, Huijgens PC, von Blomberg Jakobs C, Van Geijn HP. Underlying disorders associated with severe early onset pre-eclampsia. Am J Obstet Gynecol 1995; 173: 1042-8.
- 11 Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340: 9-13.
- 12 Dizon DSTownson, Nelson LM, Easton K, Ward K. The factor V Leiden mutation may predispose women to severe pre-eclampsia. Am J Obstet Gynecol 1996; 174: 902-5.
- 13 Van Pampus MG, Dekker GA, Wolf H, Huijgens PC, Koopman MM, von Blomberg BM, Buller HR. High prevalence of haemostatic abnormalities in women with a history of severe pre-eclampsia. Am J Obstet Gynecol 1999; 180: 1146-50.
- 14 Grandone E, Margaglione M, Collaizzo D, Cappucci G, Paladini D, Martinelli P, montanaro S, Pavone G, Di Minno G. Factor V Leiden, C>T MTHFR polymorphism and genetic susceptibility to pre-eclampsia. Thromb Haemost 1997; 77: 1052-4.
- 15 Lindoff C, Martinsson G, Segelmark M, Thysell H, Astedt B. Pre-eclampsia is associated with a reduced response to activated protein C. Am J Obstet Gynecol 1997; 176: 457-60.
- 16 Lindqvist PG, Svensson PJ, Marsaal K, Grennert L, Luterkort M, Dahlback B. Activated protein C resistance (FV:Q506) and pregnancy. Thromb Haemost 1999; 81: 532-7.
- 17 Livingstone JC, Barton JR, Park V, Haddad B, Phillips O, Sibai BM. Maternal and fetal inherited thrombophilias are not related to the development of severe pre-eclampsia. Am J Obstet Gynecol 2001; 185: 153-7.
- 18 De Groot CJ, Bloemenkamp KW, Duvekot EJ, Helmerhorst FM, Bertina RM, Van Der Meer F, De Ronde H, Oel SG, Kanhal HHH, Rosendaal FR. Pre-eclampsia and genetic risk factors for thrombosis: A case control study. Am J Obstet Gynecol 1999; 181: 975-80.
- 19 Kim YJ, Williamson RA, Murray JC, Andrews J, Pietscher JJ, Peraud PJ, Merrill DC. Genetic susceptibility to pre-eclampsia: Roles of cytosine to thymine substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase, 68base pair insertion at nucleotide 844 of the gene for cystathione b-synthase, and factor V Leiden mutation. Am J Obstet Gynecol 2001; 184: 1211-7.
- 20 O’Shaughnessy KM, Fu B, Ferraro F, Lewis I, Downing S, Morris NH. Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian pre-eclampsia cohort. Hypertension 1999; 33: 1338-41.
- 21 Murphy RP, Donoghue C, Nailen RJ, D’Mello M, Regan C, Whitehead AS, Fitzgerald DJ. Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy. Arterioscler Thromb Vasc Biol 2000; 20: 266-70.
- 22 Morrison ER, Miedzybrodzka ZH, Campbell DM, Haites NE, Wilson BJ, Watson MS, Greaves M, Vickers MA. Prothrombotic Genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. Thromb Haemost 2002; 87: 779-85.
- 23 Pabinger I, Grafenhofer H, Kaider A, Ilic A, Eichinger S, Quehenberger P, Husslein P, Mannhalter C, Lechner K. Pre-eclampsia and fetal loss in women with a history of venous thromboemboism. Arterioscler Thromb Vasc Biol 2001; 21: 874-9.
- 24 Clark P, Sattar N, Walker ID, Greer IA. The Glasgow Outcome, APCR and lipid (GOAL) Pregnancy study: Significance of pregnancy associated activated protein C resistance. Thromb Haemost 2001; 85: 30-5.